HOME Top Market Reports Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: April 2017
Report Code: MD 5190

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global perfusion systems market is expected to reach USD 1,198.8 Million by 2021 from USD 989.4 Million in 2016, at a CAGR of 3.9%. The growth of the market can be attributed to the increasing prevalence of cardiovascular & respiratory diseases, initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market.

The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region. By component, the cardiopulmonary perfusion systems market is segmented into heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas, and other components. The oxygenators segment accounted for the largest share of the cardiopulmonary perfusion systems market in 2016.

Based on technique, the ex vivo organ perfusion systems market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held the largest share of the ex vivo organ perfusion systems market in 2016 and is also projected to grow at the highest CAGR during the forecast period.

The global cell perfusion systems market is segmented based on the type, as bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure-driven perfusion systems, and small-mammal organ perfusion systems. The bioreactor perfusion systems segment held the largest share of the cell perfusion systems market in 2016 and is projected to register the highest CAGR during the forecast period.

Geographically, North America is estimated to account for the largest share of the global market, followed by Europe.  The Asia-Pacific region is expected to witness the highest growth in the market during the forecast period.  This growth will be particularly centered on China, Japan, and India.

The major players in the cardiopulmonary perfusion systems market include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany). The major players in the ex vivo organ perfusion systems market are Lifeline Scientific, Inc. (U.S.) and XVIVO Perfusion AB (Sweden), while, Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.) are some of the leading players in the cell perfusion systems market.

Target Audience: 

  • Perfusion systems and related devices manufacturing companies
  • Suppliers and distributors of perfusion systems and components
  • Organ preservation and devices providers
  • Hospitals, medical colleges, biopharmaceutical industries, R&D institutes
  • Teaching hospitals and academic medical centers (AMCs)
  • Government bodies and regulatory authorities
  • Business research and consulting service providers
  • Venture capitalists

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes perfusion systems market into the following segments:

Cardiopulmonary Perfusion Systems, by Component

  • Heart-lung Machines
  • Perfusion Pumps
  • Oxygenators
  • Monitoring Systems
  • Cannulas
  • Other Components

Cell Perfusion Systems Market, by Type

  • Bioreactor Perfusion Systems
  • Microfluidic Perfusion Systems
  • Gravity/Pressure-driven Perfusion Systems
  • Small-mammal Organ Perfusion Systems

Ex Vivo Organ Perfusion Systems Market, by Technique

  • Hypothermic Machine Perfusion Systems
  • Normothermic Machine Perfusion Systems

Perfusion Systems Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization option is available for the report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the Top three companies
  • Detailed analysis and profiling of additional market players (up to 3)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 29)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 33)
    4.1 Perfusion Systems: Market Overview
    4.2 Geographic Analysis: Perfusion Systems Market, By Type (2016)
    4.3 Cell Perfusion Systems Market, By Type, 2016 vs 2021
    4.4 Geographic Snapshot of the Market

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases
                    5.2.1.2 Rising Number of Organ Transplantations
                               5.2.1.2.1 Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
                               5.2.1.2.2 Government and NGO Initiatives to Encourage Organ Donation
                    5.2.1.3 Increasing Investments in Cell-Based Research
                    5.2.1.4 Increase in Biologic Manufacturing
           5.2.2 Restraints
                    5.2.2.1 High Cost of Organ Transplantation
                    5.2.2.2 Ethical Concerns and High Cost of Cell-Based Research
           5.2.3 Opportunities
                    5.2.3.1 Increasing Pharmaceutical Research in Emerging Markets
                    5.2.3.2 Rising Preference for Continuous Manufacturing
           5.2.4 Challenge
                    5.2.4.1 Organ Supply-Demand Gap

6 Cardiopulmonary Perfusion Systems Market, By Component (Page No. - 43)
    6.1 Introduction
    6.2 Oxygenators
    6.3 Heart-Lung Machines
    6.4 Perfusion Pumps
    6.5 Cannulas
    6.6 Monitoring Systems
    6.7 Other Components
           6.7.1 Arterial Filters
           6.7.2 Reservoirs
           6.7.3 Data Management Systems
           6.7.4 Cardioplegia Delivery Systems
           6.7.5 Heat Exchangers
           6.7.6 Accessories

7 Cell Perfusion Systems Market, By Type (Page No. - 49)
    7.1 Introduction
    7.2 Bioreactor Perfusion Systems
    7.3 Microfluidic Perfusion Systems
    7.4 Gravity Or Pressure-Driven Perfusion Systems
    7.5 Small-Mammal Organ Perfusion Systems

8 EX Vivo Organ Perfusion Market, By Technique (Page No. - 53)
    8.1 Introduction
    8.2 Hypothermic Machine Perfusion
    8.3 Normothermic Machine Perfusion

9 Global Perfusion Systems Market, By Region (Page No. - 57)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
                    9.2.1.1 Rise in Cardiovascular Disease Prevalence
                    9.2.1.2 Technological Advancements in Organ Preservation
                    9.2.1.3 Increasing Organ Transplants
                    9.2.1.4 Introduction of the 21st Century Cures Act
                    9.2.1.5 Favorable Scenario for Cell Research, Growing Research Funding
                    9.2.1.6 Growth of the Pharmaceutical and Biotechnology Sector
           9.2.2 Canada
                    9.2.2.1 Increasing Incidences of Heart Diseases
                    9.2.2.2 Favorable Reimbursement Scenario for Living Donors Within Some Provinces
                    9.2.2.3 Increasing Investment in Regenerative Medicine Research Projects
    9.3 Europe
           9.3.1 Rapidly Aging Population, High Prevalence of Cardiovascular Diseases in Europe
           9.3.2 Europe-5
                    9.3.2.1 Changes in Organ Donation Laws in Wales
                    9.3.2.2 Strong Academic and Research Base in Germany
                    9.3.2.3 Funding for Research in the U.K.
                    9.3.2.4 Increasing Cancer Research in France
                    9.3.2.5 Italy: Growing Biotech Industry to Aid Market Growth
           9.3.3 RoE
                    9.3.3.1 Strong Presence of Pharmaceutical and Biotechnology Companies
                    9.3.3.2 Increasing Research in Denmark and Sweden
    9.4 Asia-Pacific
           9.4.1 Increasing Aging Population, Rise in Cardiovascular Surgery
           9.4.2 Japan
                    9.4.2.1 Rising Organ Donations and Transplants
                    9.4.2.2 Rise in Vaccine Production in Japan
                    9.4.2.3 Regenerative Medicine and Biomedical & Medical Research in Japan
           9.4.3 China
                    9.4.3.1 Regulatory Framework for Voluntary Organ Donations
                    9.4.3.2 Increasing Government Interest in Biomedical and Biotechnology Industries
                    9.4.3.3 Growth of the Pharmaceutical and Biotechnology R&D Industry and Cros Sector
           9.4.4 India
                    9.4.4.1 Religious Beliefs and Lack of Healthcare Infrastructure in India
                    9.4.4.2 Growing Pharmaceutical and Biotechnology Industry, Government Initiatives
           9.4.5 Rest of Asia-Pacific
                    9.4.5.1 Taiwan: Increasing Government Support for Academic and Commercial R&D
                    9.4.5.2 Establishment of R&D Centers in Singapore
                    9.4.5.3 Korea-U.S. Free Trade Agreement (Korus)
    9.5 Rest of the World
           9.5.1 Campaigns to Encourage Organ Donation in Brazil
           9.5.2 Flourishing Biotechnology and Pharmaceutical Markets in Brazil
           9.5.3 Significant Developments in the Pharmaceutical Market in Africa
           9.5.4 Favorable Regulatory Environment in Saudi Arabia, Iran, and Israel

10 Competitive Landscape (Page No. - 97)
     10.1 Introduction
             10.1.1 Vanguards
             10.1.2 Innovator
             10.1.3 Dynamic
             10.1.4 Emerging
     10.2 Competitive Benchmarking
             10.2.1 Product Offerings
             10.2.2 Business Strategy

*Top 13 Companies Analyzed for This Studies are - Getinge AB (Sweden), Medtronic PLC (Ireland), Terumo Corporation (Japan), Livanova PLC (U.K.), Xenios AG (Germany), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Nipro Corporation (Japan), Harvard Bioscience, Inc. (U.S.), ALA Scientific Instruments, Inc. (U.S.), Lifeline Scientific, Inc. (U.S.), and Xvivo Perfusion AB (Sweden).

11 Company Profile (Page No. - 101)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Getinge AB
     11.2 Medtronic PLC
     11.3 Livanova PLC
     11.4 Terumo Corporation
     11.5 Nipro Corporation
     11.6 Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
     11.7 Repligen Corporation
     11.8 Spectrum Laboratories, Inc.
     11.9 Merck KGaA
     11.10 Harvard Bioscience, Inc.
     11.11 ALA Scientific Instruments, Inc.
     11.12 Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
     11.13 Xvivo Perfusion AB

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 144)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
             12.3.1 Features and Benefits of RT
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (74 Tables)

Table 1 Biomanufacturing Projects Announced in 2015 and 2016
Table 2 Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 3 Oxygenators Market Size, By Region, 2014-2021 (USD Million)
Table 4 Heart-Lung Machines Market Size, By Region, 2014-2021 (USD Million)
Table 5 Perfusion Pumps Market Size, By Region, 2014-2021 (USD Million)
Table 6 Cannulas Market Size, By Region, 2014-2021 (USD Million)
Table 7 Monitoring Systems Market Size, By Region, 2014-2021 (USD Million)
Table 8 Other Components Market Size, By Region, 2014-2021 (USD Million)
Table 9 Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 10 Bioreactor Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 11 Microfluidic Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 12 Gravity Or Pressure-Driven Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 13 Small-Mammal Organ Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 14 EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 15 Advantages and Disadvantages of the HMP Technique
Table 16 Hypothermic Machine Perfusion Market Size, By Region, 2014-2021 (USD Million)
Table 17 Normothermic Machine Perfusion Market Size, By Region, 2014-2021 (USD Million)
Table 18 Global Market Size, By Region, 2014-2021 (USD Million)
Table 19 Global Market Size, By Type, 2014-2021 (USD Million)
Table 20 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 21 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 22 North America: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 23 North America: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 24 North America: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 25 Number of Organ Transplants in the U.S. (2014-2016)
Table 26 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 27 U.S.: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 28 U.S.: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 29 U.S.: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 30 Canada: Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 31 Canada: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 32 Canada: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 33 Canada: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 34 Europe: Market Size, By Region, 2014-2021 (USD Million)
Table 35 Europe: Market Size, By Type, 2014-2021 (USD Million)
Table 36 Europe: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 37 Europe: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 38 Europe: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 39 Europe-5: Market Size, By Type, 2014-2021 (USD Million)
Table 40 Europe-5: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 41 Europe-5: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 42 Europe-5: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 43 Indicative List: Companies Headquartered in RoE Countries
Table 44 RoE: Market Size, By Type, 2014-2021 (USD Million)
Table 45 RoE: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 46 RoE: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 47 RoE: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 48 Asia-Pacific: Market Size, By Country, 2014-2021 (USD Million)
Table 49 Asia-Pacific: Market Size, By Type, 2014-2021 (USD Million)
Table 50 Asia-Pacific: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 51 Asia-Pacific: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 52 Asia-Pacific: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 53 Number of Organ Donations and Transplants in Japan (2013-2016)
Table 54 Japan: Market Size, By Type, 2014-2021 (USD Million)
Table 55 Japan: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 56 Japan: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 57 Japan: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 58 China: Market Size, By Type, 2014-2021 (USD Million)
Table 59 China: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 60 China: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 61 China: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 62 India: Market Size, By Type, 2014-2021 (USD Million)
Table 63 India: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 64 India: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 65 India: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 66 RoAPAC: Market Size, By Type, 2014-2021 (USD Million)
Table 67 RoAPAC: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 68 RoAPAC: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 69 RoAPAC: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 70 Number of Organ Donations (2008 vs 2015)
Table 71 RoW: Market Size, By Type, 2014-2021 (USD Million)
Table 72 RoW: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 73 RoW: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 74 RoW: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)


List of Figures (61 Figures)

Figure 1 Perfusion Systems Market Segmentation
Figure 2 Perfusion Systems Market: Research Methodology Steps
Figure 3 Sampling Frame: Primary Research
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design
Figure 8 Data Triangulation Methodology
Figure 9 Perfusion Systems Market, By Type: Cardiopulmonary Perfusion Systems Segment Accounted for the Largest Market Share in 2016
Figure 10 Cardiopulmonary Perfusion Systems Market Size, By Component, 2016 vs 2021
Figure 11 EX Vivo Organ Perfusion Market Size (USD Million), By Technique, 2016 vs 2021
Figure 12 Cell Perfusion Systems Market Size, By Type, 2016 vs 2021
Figure 13 Geographic Snapshot of the Market
Figure 14 North America Accounted for the Largest Share of the Perfusion Systems Market in 2016
Figure 15 Cardiopulmonary Perfusion Segment Dominated the Perfusion Systems Market in 2016
Figure 16 Bioreactor Perfusion Systems Will Continue to Dominate the Cell Perfusion Systems Market in 2021
Figure 17 North America to Register the Highest CAGR During the Forecast Period
Figure 18 Global Market Share, By Region (2016–2021)
Figure 19 North America: Market Snapshot
Figure 20 NIH Spending on Stem Cell Research, 2013-2016 (USD Billion)
Figure 21 Number of New Biotechnology and Pharmaceutical Companies, 2014-2016
Figure 22 Europe: Market Snapshot
Figure 23 APAC: Market Snapshot
Figure 24 RoW: Market Snapshot
Figure 25 Dive Chart
Figure 26 Getinge AB: Company Snapshot (2016)
Figure 27 Getinge AB: Product Offering Scorecard
Figure 28 Getinge AB: Business Strategy Scorecard
Figure 29 Medtronic PLC: Company Snapshot (2016)
Figure 30 Medtronic PLC: Product Offering Scorecard
Figure 31 Medtronic PLC: Business Strategy Scorecard
Figure 32 Livanova PLC: Company Snapshot (2015)
Figure 33 Livanova PLC: Product Offering Scorecard
Figure 34 Livanova PLC: Business Strategy Scorecard
Figure 35 Terumo Corporation: Company Snapshot (2015)
Figure 36 Terumo Corporation: Product Offering Scorecard
Figure 37 Terumo Corporation: Business Strategy Scorecard
Figure 38 Nipro Corporation: Company Snapshot (2015)
Figure 39 Nipro Corporation: Product Offering Scorecard
Figure 40 Nipro Corporation: Business Strategy Scorecard
Figure 41 Xenios AG: Product Offering Scorecard
Figure 42 Xenios AG: Business Strategy Scorecard
Figure 43 Repligen Corporation: Company Snapshot (2015)
Figure 44 Repligen Corporation: Product Offering Scorecard
Figure 45 Repligen Corporation: Business Strategy Scorecard
Figure 46 Spectrum Laboratories, Inc.: Product Offering Scorecard
Figure 47 Spectrum Laboratories, Inc.: Business Strategy Scorecard
Figure 48 Merck KGaA: Company Snapshot (2015)
Figure 49 Merck KGaA: Product Offering Scorecard
Figure 50 Merck KGaA: Business Strategy Scorecard
Figure 51 Harvard Bioscience, Inc.: Company Snapshot (2015)
Figure 52 Harvard Bioscience, Inc.: Product Offering Scorecard
Figure 53 Harvard Bioscience, Inc.: Business Strategy Scorecard
Figure 54 ALA Scientific Instruments, Inc.: Product Offering Scorecard
Figure 55 ALA Scientific Instruments, Inc.: Business Strategy Scorecard
Figure 56 Lifeline Scientific, Inc.: Company Snapshot (2015)
Figure 57 Lifeline Scientific, Inc.: Product Offering Scorecard
Figure 58 Lifeline Scientific, Inc.: Business Strategy Scorecard
Figure 59 Xvivo Perfusion AB: Company Snapshot (2015)
Figure 60 Xvivo Perfusion AB: Product Offering Scorecard
Figure 61 Xvivo Perfusion AB: Business Strategy Scorecard

The global perfusion systems market is expected to reach USD 1,198.8 Million by 2021 from USD 989.4 Million in 2016, at a CAGR of 3.9%. The growth of the market can be attributed to the increasing prevalence of cardiovascular & respiratory diseases, initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market.

The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region. By component, the cardiopulmonary perfusion systems market is segmented into heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas, and other components. The oxygenators segment accounted for the largest share of the cardiopulmonary perfusion systems market in 2016.

Based on technique, the ex vivo organ perfusion systems market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held the largest share of the ex vivo organ perfusion systems market in 2016 and is also projected to grow at the highest CAGR during the forecast period.

The global cell perfusion systems market is segmented based on the type, as bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure-driven perfusion systems, and small-mammal organ perfusion systems. The bioreactor perfusion systems segment held the largest share of the cell perfusion systems market in 2016 and is projected to register the highest CAGR during the forecast period.

Geographically, North America is estimated to account for the largest share of the global market, followed by Europe.  The Asia-Pacific region is expected to witness the highest growth in the market during the forecast period.  This growth will be particularly centered on China, Japan, and India.

Perfusion Systems Market

The major players in the cardiopulmonary perfusion systems market include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany). The major players in the ex vivo organ perfusion systems market are Lifeline Scientific, Inc. (U.S.) and XVIVO Perfusion AB (Sweden), while, Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.) are some of the leading players in the cell perfusion systems market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo